Cargando…
Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
BACKGROUND: We estimated U.S. biomedical research funding across therapeutic areas, determined the association with disease burden, and evaluated new drug approvals that resulted from this investment. METHODOLOGY/PRINCIPAL FINDINGS: We calculated funding from 1995 to 2005 and totaled Food and Drug A...
Autores principales: | Dorsey, E. Ray, Thompson, Joel P., Carrasco, Melisa, de Roulet, Jason, Vitticore, Philip, Nicholson, Sean, Johnston, S. Claiborne, Holloway, Robert G., Moses, Hamilton |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735780/ https://www.ncbi.nlm.nih.gov/pubmed/19750225 http://dx.doi.org/10.1371/journal.pone.0007015 |
Ejemplares similares
-
Requirements and Study Designs for U.S. Regulatory Approval of Influenza Home Tests
por: Yang, Tony, et al.
Publicado: (2022) -
Drugs and Devices: Comparison of European and U.S. Approval Processes
por: Van Norman, Gail A.
Publicado: (2016) -
Current and projected future economic burden of Parkinson’s disease in the U.S.
por: Yang, Wenya, et al.
Publicado: (2020) -
The Financing of Biomedical Research
por: Smith, Maureen A.
Publicado: (1990) -
Impressive Words: Linguistic Predictors of Public Approval of the U.S. Congress
por: Decter-Frain, Ari, et al.
Publicado: (2016)